. >>> congressman kurt schrader at our table today here to talk about prescription drug pricing. the house passed hr 3 last year. what is it and what will it do? >> it's the first attempt since the passage of medicare part d 20 years ago to reduce drug prices for americans. we hear again and again drug prices and health care costs are the biggest issue for americans right now and this would allow the united states government health and human services to negotiate drug prices. we negotiate drug prices in our private lives. we negotiate them with unions and businesses. why can't seniors, why can't americans negotiate drug prices? it's a market based principle. republicans and democrats should be able to agree to that. if your drug costs go beyond a certain point, seniors are on the hook for 35, 40, $50,000. both democrat and republican bills would limit that to 2 or $3,000. we've learned in energy and commerce, in investigating drug pricing increases, there's a whole chain of events, a lot of different actors playing into these cost increases. we need more transparency to make the